In a final set of experiments, recapitulating the initial experiments, a transgenic zebrafish was generated in which BRAFV600E was overexpressed together with ATAD2 in a p53−/− background to test whether ATAD2 expression might be sufficient for melanoma development in a setting using the tyrp1 promoter. The gene discussed is ATAD2; the disease is melanoma.